CLASS III Drug recall · Reported 25 Nov 2020 · FDA Enforcement Report

Testosterone Gel 1% per unit dose recalled by Teva Pharmaceuticals U

Teva Pharmaceuticals USA is recalling Testosterone Gel 1% per unit dose, distributed nationwide in the US. The recall was initiated on 11 Nov 2020 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot Number: 1351104, Exp 08/2021
NDC0591-2921, 0591-3216, 0591-3217
Quantity recalled12,088 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0100-2021
FDA event ID
86738
Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Manufacturer
Actavis Pharma, Inc.
Classification
Class III
Status
Terminated
Recall initiated
11 Nov 2020
FDA classified
20 Nov 2020
Reported
25 Nov 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

11 Nov 2020Recall initiated by company
20 Nov 2020Classified by FDA+9 days
25 Nov 2020Published in enforcement report+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.

Where it was distributed

Product was distributed Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Which lots are affected?

Lot Number: 1351104, Exp 08/2021

Where was it sold?

Product was distributed Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 281

Other Testosterone recalls

All 91